NCT06698965 2024-11-21Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and CarboplatinShanghai Chest HospitalPhase 2 Recruiting52 enrolled